Glaxosmithkline Llc Pac (Gsk Pac) MAR MONTHLY Filings
Cycle | Date Filed | End Date | Amendment | Receipts | Spending | Cash |
---|---|---|---|---|---|---|
2024 | March 11 | Feb. 29 | $22,661.29 | $2,536.23 | $69,442.40 | |
2024 | March 6, 2023 | Feb. 28, 2023 | $22,463.31 | $4,778.90 | $82,540.51 | |
2022 | April 12, 2022 | Feb. 28, 2022 | Compare to original | $23,541.01 | $79.25 | $166,102.47 |
2022 | March 3, 2021 | Feb. 28, 2021 | $24,402.55 | $82.17 | $160,710.62 | |
2020 | March 13, 2020 | Feb. 29, 2020 | $24,712.99 | $20.47 | $206,953.92 | |
2020 | March 20, 2019 | Feb. 28, 2019 | $25,849.21 | $4,650.19 | $169,254.17 | |
2018 | March 20, 2018 | Feb. 28, 2018 | $32,158.87 | $2,560.20 | $150,276.76 | |
2018 | March 20, 2017 | Feb. 28, 2017 | $32,047.29 | $66.77 | $146,586.09 | |
2016 | March 18, 2016 | Feb. 29, 2016 | $29,902.74 | $4,551.68 | $198,924.02 | |
2016 | March 18, 2015 | Feb. 28, 2015 | $39,216.99 | $50.64 | $235,521.66 | |
2014 | March 19, 2014 | Feb. 28, 2014 | $42,330.67 | $68,194.70 | $159,266.25 | |
2014 | March 20, 2013 | Feb. 28, 2013 | $41,883.57 | $37.01 | $154,967.25 | |
2012 | March 16, 2012 | Feb. 29, 2012 | $42,449.86 | $43.03 | $160,375.85 | |
2012 | March 18, 2011 | Feb. 28, 2011 | $44,864.40 | $39,582.83 | $153,429.07 | |
2010 | March 19, 2010 | Feb. 28, 2010 | $63,388.30 | $64,060.03 | $196,949.36 | |
2010 | Sept. 18, 2009 | Feb. 28, 2009 | Compare to original | $71,386.00 | $27,936.00 | $219,860.37 |
2008 | Sept. 18, 2009 | Feb. 29, 2008 | Compare to original | $76,047.40 | $71,350.00 | $162,274.00 |
2008 | March 15, 2007 | Feb. 28, 2007 | $77,991.18 | $11,500.00 | $270,075.06 | |
2006 | March 15, 2006 | Feb. 28, 2006 | $80,972.60 | View | $615,588.00 | |
2006 | March 16, 2005 | Feb. 28, 2005 | $82,672.50 | $36,950.00 | $324,437.00 | |
2004 | March 15, 2004 | Feb. 29, 2004 | View | View | ||
2004 | March 19, 2003 | Feb. 28, 2003 | View | View | ||
2002 | Oct. 29, 2002 | Feb. 28, 2002 | View | View | ||
2002 | March 14, 2001 | Feb. 28, 2001 | View | View |